As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
All content for Built Environment Matters is the property of Bryden Wood and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
UK Industrial Strategy: Analysis, Gaps, and the Path to Growth | Bryden Wood Podcast
Built Environment Matters
32 minutes
5 months ago
UK Industrial Strategy: Analysis, Gaps, and the Path to Growth | Bryden Wood Podcast
Welcome to the Bryden Wood Podcast. In this episode, 'UK Industrial Strategy: Analysis, Gaps, and the Path to Growth', co-founder Martin Wood, Technical Director Adrian La Porta, and John Dyson examine the UK's recently published industrial strategy. The discussion highlights the positive aspects of the strategy, such as establishing a 10-year framework for economic stability , identifying key high-growth sectors (advanced manufacturing, clean energy, creative industries, defence, digital/tec...
Built Environment Matters
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
